Abstract:Objective: In order to evaluate disease perception of asthma patients in urban China and provide evidence for further specific patient education. Methods: A multi-center, cross-sectional, questionnaire-based survey was carried out in 30 general hospitals dispersed in 30 provinces of mainland China (except for Tibet) during Oct 2015 to May 2016. Information of disease perception [Question 1: the disease nature of asthma; Question 2: medication choice of first-line in chronic asthma; Question 3: the occasion of using short-acting aerosols of receptor agonists; Question 4: perception of asthma treatment goal; Question 5: reason for not using peak flow meter (PFM)] were collected from asthma patients of outpatient department. These results were compared with the same type of survey results from 2007-2008. Results: Altogether 3 875 asthmatic outpatients were recruited. 69.0% (2 660/3 857) of the patients had right perception on the disease nature of asthma, 60.2% (2 321/3 857) of the patients considered inhaled corticosteroids (ICS)/inhaled corticosteroids plus long-acting beta2-agonists (ICS+ LABA) as daily-used first-line medication for chronic asthma. 85.7% (3 277/3 823) of the patients had right perception on the condition of using short-acting beta2-agonists (SABA). 75.4% (2 761/3 661) of the patients had right perception on asthma treatment goal. Only 10.1% (388/3 837) of the patients used PFM. Of the reasons for not using PFM, 65.2% (2 518/3 860) of the patients chose doctors never introduced. Among the 10 cities, which were also involved in the asthma control survey in 2007-2008, 71.1% (968/1 361) of the patients had right perception on the disease nature of asthma, 61.6% (839/1 362) of the patients considered ICS/ICS+ LABA as daily-used first-line medication for chronic asthma. 88.7% (1 207/1 361) of the patients had right perception on the condition of using SABA. 74.5% (1 013/1 360) of the patients had right perception on asthma treatment goal. 17.9% (244/1 360) of the patients used PFM. Of the reasons for not using PFM, 76.2% (931/1 221) of the patients chose doctors never introduced. Compared to the survey conducted in 2007-2008, the perception on disease nature and medication choice as daily-used first-line medication for chronic asthma significantly improved, the perception on occasion of using SABA and asthma treatment goal was comparable, while the rate of PFM usage showed no significant improvement. In reasons of not using PFM, doctors never introduced ranked the first. Conclusions: Compared to the similar survey conducted in 2007-2008, the overall status of disease perception of asthma patients has been improved in urban China, while the rate of PFM usage showed no significant improvement. Asthma education on asthma and asthma self-management should be further pushed forward.

[Review and perspective of clinical research involving chest tightness variant asthma in China].

Research Progress on the Pathogenesis of Chest Tightness Variant Asthma Characterized by Chest Tightness.

[Investigation on Cognition, Diagnosis and Treatment Status of Chest Tightness Variant Asthma among Chinese Pediatricians].

Response of Patients with Chest Tightness Variant Asthma with Routine Asthma Management Regimen: A One-Year Multicenter, Prospective Real-life Study

Therapeutic Response of Patients with Chest Tightness Variant Asthma: A One-Year Multicenter, Prospective Real-Life Study

Response of patients with chest tightness variant asthma with routine asthma treatment regimen: A 1‐year multicenter, prospective, real‐world study

Airway Inflammation, Bronchial Hyperresponsiveness, and Anti-Asthma Therapy Responses in Cough Variant Asthma and Classic Asthma with FEV1%≥80% Predicted

Perspectives and Management of Atypical Asthma in Chinese Specialists and Primary Care Practitioners—A Nationwide Questionnaire Survey

A New Phenotype of Asthma: Chest Tightness As the Sole Presenting Manifestation

A narrative review of clinical studies of herbal treatment of difficult to manage asthma

The Systematic Review Analysis of Documents of Diagnosis and Treatment of Cough Variant Asthma Published in the Last Two Years

Active ingredients from Chinese medicine plants as therapeutic strategies for asthma: Overview and challenges

Clinical and Inflammatory Characteristics of the Chinese APAC Cough Variant Asthma Cohort

[Trends of Asthma Control, Disease Management and Perception in China].

Acupuncture Treatment for Cough-Variant Asthma: A Meta-Analysis

Proteomic Analysis of Sputum Reveals Novel Biomarkers for Various Presentations of Asthma.

[Evaluation of Asthma Disease Perception from China National Asthma Control Survey].

Quantitative CT Metrics for the Prediction of Therapeutic Effect in Asthma.

[The current status of the study on asthma in China]

[Warning symptoms of asthma attack and asthma self-management: a national asthma control survey from China].

The efficacy of Tuina for asthma: a protocol for a systematic review and meta-analysis